M. Duchesne

发表

From Random Screening of Chemical Libraries to the Optimization of FPP-Competitive Inhibitors of Farnesyltransferase

P. Vrignaud, M. Bissery, J. Riou, 2001 .

Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferase

F. Clerc, B. Tocqué, J. Becquart, 1995 .

Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling.

F. Clerc, B. Tocqué, F. Schweighoffer, 1993, Science.

Polypeptide composition of an adenovirus type 5 used in cancer gene therapy.

S. Bouvier, F. Blanche, L. Maton, 2001, Journal of chromatography. A.

Phenylalanine ammonia-lyase in tobacco mosaic virus-infected hypersensitive tobacco. Density-labelling evidence of de novo synthesis.

L. Hirth, B. Fritig, M. Duchesne, 1977, Biochimica et biophysica acta.

A Role for Sam68 in Cell Cycle Progression Antagonized by a Spliced Variant within the KH Domain*

B. Tocqué, F. Schweighoffer, F. Maurier, 1997, The Journal of Biological Chemistry.

Initial characterization of a HTC cell variant partially resistant to the anti-proliferative effect of ornithine decarboxylase inhibitors.

C. Tardif, P. Mamont, M. Duchesne, 1978, Experimental cell research.

Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase.

P. Mamont, M. Duchesne, P. Bey, 1978, Biochemical and biophysical research communications.

Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase.

D. Scherman, F. Clerc, G. Byk, 1997, Bioorganic & medicinal chemistry.

Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response

Isobel S Okoye, Paige Lacy, M. Duchesne, 2022, Frontiers in Immunology.

Synthesis, purification and biological properties of a truncated mutant form of human tissue plasminogen activator produced in E. Coli

B. Cambou, P. Denéfle, A. Uzan, 1991 .

Synthesis and Purification of Active Human Tissue Plasminogen Activator From Escherichia coli

P. Denéfle, J. Mayaux, P. Sarmientos, 1989, Bio/Technology.

Minimal FLAG Sequenc e Useful in the Functiona l Epitope Tagging of H-Ra s

B. Tocqué, F. Schweighoffer, F. Maurier, 2002 .

Solution structure of the N-terminal SH3 domain of Grb2 by 1H NMR and identification of its ligand binding region

B. Roques, B. Tocqué, C. Garbay, 1995 .

Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.

R. Meloen, G. Belsham, D. O. Morgan, 1989, The Journal of general virology.

Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies.

M. Duchesne, T. Cartwright, F. Boucher, 1984, The Journal of general virology.

Production andCharacterization ofMonoclonal Antibodies against Serotype Strains ofPseudomonas aeruginosa

M. Duchesne, 1987 .

Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling‐involved sequence.

N. Jullian, B. Roques, B. Tocqué, 1994, The EMBO journal.

NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos

B. Roques, B. Tocqué, C. Garbay, 1994, Nature Structural Biology.

Effect of alpha-methyl ornithine on ornithine decarboxylase activity of rat hepatoma cells in culture.

P. McCann, C. Tardif, P. Mamont, 1977, Biochemical and biophysical research communications.

Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific λ and irrelevant κ light chains

O. Cochet, B. Tocqué, F. Schweighoffer, 1998 .

A Ras-GTPase-activating protein SH3-domain-binding protein

L. Debussche, B. Tocqué, F. Schweighoffer, 1996, Molecular and cellular biology.

Monoclonal antibodies against synovial collagenase: use for immunopurification and characterization of the latent and active enzyme.

C. Pernelle, M. Duchesne, T. Cartwright, 1988, Collagen and related research.

Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian ras proteins and is oncogenic in NIH3T3 cells.

B. Tocqué, F. Schweighoffer, M. Duchesne, 1993, The Journal of biological chemistry.

Local constrained shifty pseudopeptides inhibitors of rasfarnesyl transferase

D. Scherman, F. Clerc, G. Byk, 1995 .

SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)

L. Khiroug, J. Ravetch, H. Fukuyama, 2018, Alzheimer's Research & Therapy.

SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)

L. Khiroug, J. Ravetch, H. Fukuyama, 2018, Alzheimer's Research & Therapy.

Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.

O. Cochet, B. Tocqué, F. Schweighoffer, 1998, Molecular immunology.

Differential Interactions of the Growth Factor Receptor-bound Protein 2 N-SH3 Domain with Son of Sevenless and Dynamin

D. Cussac, B. Roques, B. Tocqué, 1998, The Journal of Biological Chemistry.

The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.

M. Jacquet, D. Landais, B. Tocqué, 1993, Oncogene.

Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis

F. Delalande, F. Poirier, A. High, 2007, Neurobiology of Aging.

SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 Patients

T. Hobman, J. Lewis, N. Govindasamy, 2023, Viruses.

Cloning of a Grb2 isoform with apoptotic properties.

B. Tocqué, F. Schweighoffer, M. Multon, 1994, Science.